No, of course not. I asked that, though, as a larger question regarding the sector stability of this market. OK, "media stocks" are taking a beating, and with spillover effects today's overall market (S&P) is down about 1% at this time. But I've been watching Gilead, and today it's down about 3%. So I have to wonder about the rationality of a market that drives down a stock in a sector that has absolutely nothing to do with "media" at a ratio 3x that of the overall market. How can we make a rational decision regarding the likely direction of a stock like Gilead when it is apparently heavily influenced by factors that have absolutely nothing to do with the company or it's sector?
Edit/Add: The following by Scott, from his "Media Stocks Obliterated" post:
"Obviously not technical in nature or anything beyond a feeling, but market feels as if there's considerable underlying unease."
Yes, exactly.
Comments
CELG is not cheap, but they have laid out what they see as the next 5 years. It may be a bumpy ride, but the company has a convincing track record. If they can meet projections, I think there's more room to the upside (but again, between here-and-there may be bumpy.)
Have been adding to Ecolab (ECL), the definition of enjoyably dull - down maybe half a percent on a lousy day and was up earlier. Abbott (ABT) also not doing much.
Thanks-
I'll also note that something that interests me is the Walgreens (WBA) partnership with Theranos.
Walgreens has Theranos stations in 40 or so stores but will be rolling out to many more.
http://www.businessinsider.com/science-of-elizabeth-holmes-theranos-2015-4
http://fortune.com/2015/05/07/theranos-jump-starts-consumer-lab-testing/
http://www.walgreens.com/pharmacy/lab-testing/home.jsp
Walgreens also has a stake in Amerisource Bergen (ABC), which has done rather well.